SAKAR — Sakar Healthcare Share News
0.000.00%
Last trade - 00:00- IN₹19.53bn
- IN₹20.23bn
- IN₹2.52bn
Brief: Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners
Brief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar
Brief: Sakar Healthcare Says Granted Two More Marketing Authorizations In EU
India's Sakar Healthcare rises on nod to market cancer injection in EU
Brief: Sakar Healthcare Says Granted Second Marketing Authorization For Oncology Injection In EU
Brief: Sakar Healthcare Enters 9 Agreements To Boost Oncology Product Exports
Brief: Sakar Healthcare Re-Appoints Sanjay S. Shah As MD
India's Sakar Healthcare up on eyeing anti-cancer business expansion abroad
Brief: Sakar Healthcare Starts Product Dossier Submission To Overseas Countries
India's Sakar Healthcare jumps on oncology products' deal
Brief: Sakar Healthcare Says Sakar's Oncology Unit Receives EU Gmp Approval
Brief: Sakar Healthcare To Issue Shares, Warrants By Preferential Issue
Brief: Sakar Healthcare Approved Issuance Of Shares By Way Of Preferential Issue On Private Placement Basis
Brief: Sakar Healthcare Gets WHO GMP Approval For Oncology Injection Unit
India's Sakar Health up after deal with Swiss cos for oncology products
Brief: Sakar Healthcare Entered Into Agreement With Ferring Pharmaceuticals And Bazell Pharma Llp
Brief: Sakar Healthcare Entered Into Agreement With Pharmaceutical Oriented Services